Variables | Before propensity score (PS) matching | After propensity score (PS) matching | ||||||
---|---|---|---|---|---|---|---|---|
Overall (326) | Early (110) | Late (216) | P-value | Overall (210) | Early (105) | Late (105) | P-value | |
Age (years), Mean (SD) | 57.5 (20.17) | 66.9 (16.55) | 52.7 (20.19) | < .0001* | 58.5 (18.41) | 66.8 (16.65) | 50.2 (16.29) | < .0001* |
Male, n (%) | 234 (72.0) | 68 (62.4) | 166 (76.9) | 0.0061^^ | 147 (70.3) | 66 (63.5) | 81 (77.1) | 0.0304^^ |
Weight (kg), Mean (SD) | 71.6 (20.47) | 72.7 (22.87) | 71.0 (19.17) | 0.8841^ | 72.3 (22.18) | 72.8 (23.17) | 71.9 (21.27) | 0.9928^ |
Body mass Index, Mean (SD) | 27.2 (16.77) | 29.6 (27.10) | 26.0 (7.13) | 0.1379^ | 28.0 (20.42) | 29.8 (27.72) | 26.3 (8.16) | 0.3033^ |
Admission category | ||||||||
Medical, n (%) | 179 (55.1) | 78 (71.6) | 101 (46.8) | 0.0018^^ | 124 (59.3) | 75 (72.1) | 49 (46.7) | 0.0054** |
Surgical, n (%) | 44 (13.5) | 9 (8.3) | 35 (16.2) | 28 (13.4) | 7 (6.7) | 21 (20.0) | ||
Trauma, n (%) | 47 (14.5) | 9 (8.3) | 38 (17.6) | 26 (12.4) | 9 (8.7) | 17 (16.2) | ||
Burn, n (%) | 8 (2.5) | 1 (0.9) | 7 (3.2) | 3 (1.4) | 1 (1.0) | 2 (1.9) | ||
Neuro, n (%) | 35 (10.8) | 8 (7.3) | 27 (12.5) | 21 (10.0) | 8 (7.7) | 13 (12.4) | ||
Transplant, n (%) | 12 (3.7) | 4 (3.7) | 8 (3.7) | 7 (3.3) | 4 (3.8) | 3 (2.9) | ||
Comorbidity | ||||||||
Diabetes mellitus, n (%) | 142 (49.1) | 62 (64.6) | 80 (41.5) | 0.0002^^ | 93 (50.5) | 59 (64.8) | 34 (36.6) | 0.0001^^ |
Hypertension, n (%) | 154 (52.0) | 66 (66.0) | 88 (44.9) | 0.0006^^ | 102 (53.7) | 62 (65.3) | 40 (42.1) | 0.0014^^ |
Chronic Liver disease, n (%) | 27 (10.3) | 7 (8.2) | 20 (11.2) | 0.4533^^ | 14 (8.6) | 7 (8.8) | 7 (8.4) | 0.9426^^ |
Heart failure, n (%) | 48 (17.8) | 28 (30.4) | 20 (11.2) | < 0.0001^^ | 37 (21.5) | 27 (31.0) | 10 (11.8) | 0.0021^^ |
Cerebrovascular accident, n (%) | 31 (11.4) | 16 (16.8) | 15 (8.5) | 0.0384^^ | 26 (14.7) | 16 (17.8) | 10 (11.5) | 0.2378^^ |
Chronic obstructive pulmonary disease (COPD), n (%) | 16 (6.2) | 8 (9.3) | 8 (4.7) | 0.1442^^ | 13 (7.9) | 8 (9.9) | 5 (6.0) | 0.3612^^ |
Severity score within 24 h of ICU admission | ||||||||
Modified Sequential Organ Failure Assessment (mSOFA), Median (Q1, Q3) | 5.5 (4.00, 7.00) | 5.0 (4.00, 8.00) | 6.0 (4.00, 7.00) | 0.9329^ | 5.0 (4.00, 7.00) | 5.0 (4.00, 8.00) | 5.0 (4.00, 7.00) | 0.6435^ |
APACHE II Score, Median (Q1, Q3) | 14.5 (9.00, 20.00) | 15.0 (11.00, 21.00) | 14.0 (9.00, 20.00) | 0.2706^ | 15.0 (11.00, 21.00) | 15.0 (11.00, 21.00) | 13.0 (9.00, 20.00) | 0.2249* |
Baseline within 24 h of ICU admission | ||||||||
Admission Glasgow Coma Scale (GCS), Median (Q1, Q3) | 13.0 (7.00, 15.00) | 11.0 (6.00, 15.00) | 14.0 (7.00, 15.00) | 0.2239^ | 13.0 (8.00, 15.00) | 11.0 (6.00, 15.00) | 14.0 (9.00, 15.00) | 0.0606^ |
Mechanical ventilation within 24 h of ICU admission, n (%) | 143 (44.3) | 42 (38.9) | 101 (47.0) | 0.3663** | 90 (43.5) | 42 (40.8) | 48 (46.2) | 0.3091** |
AKI within 24 h of ICU admission, n (%) | 47 (14.5) | 14 (12.8) | 33 (15.3) | 0.5559^^ | 40 (19.2) | 20 (19.2) | 20 (19.2) | > 0.9999^^ |
Blood glucose level (BGL) (mmol/L), Mean (SD) | 10.2 (5.18) | 10.5 (4.87) | 10.0 (5.40) | 0.2967^ | 10.7 (4.95) | 10.6 (4.85) | 10.8 (5.17) | 0.8611^ |
Lactic acid (mmol/L), Mean (SD) | 2.7 (2.40) | 2.4 (1.69) | 2.9 (2.70) | 0.7442^ | 2.7 (2.26) | 2.4 (1.71) | 2.9 (2.69) | 0.5299^ |
Serum creatinine (μmol/L), Mean (SD) | 104.0 (73.53) | 114.6 (77.44) | 98.6 (71.07) | 0.0162^ | 105.8 (70.31) | 114.7 (78.28) | 97.0 (60.49) | 0.0586^ |
Blood urea nitrogen (BUN), Mean (SD) | 8.5 (6.49) | 9.8 (6.69) | 7.9 (6.31) | 0.0020^ | 8.6 (6.17) | 9.5 (6.35) | 7.6 (5.87) | 0.0070^ |
Hematocrit, Mean (SD) | 0.4 (0.08) | 0.3 (0.09) | 0.4 (0.08) | 0.1298^ | 0.3 (0.09) | 0.3 (0.09) | 0.4 (0.09) | 0.2032^ |
Albumin (g/L), Mean (SD) | 30.8 (6.19) | 29.5 (6.14) | 31.4 (6.12) | 0.0096* | 30.7 (6.27) | 29.5 (6.14) | 31.8 (6.21) | 0.0071* |
Platelets count (1000 × 10^6/L), Mean (SD) | 243.7 (141.00) | 256.9 (148.17) | 237.1 (137.20) | 0.2522^ | 244.7 (148.49) | 256.2 (148.29) | 233.4 (148.52) | 0.1837^ |
Alanine transaminase (ALT), Mean (SD) | 68.4 (142.17) | 46.1 (97.51) | 79.2 (158.46) | 0.0887^ | 61.7 (128.95) | 47.0 (98.51) | 75.9 (151.96) | 0.2515^ |
Aspartate aminotransferase (AST), Mean (SD) | 94.1 (232.29) | 90.9 (314.56) | 95.7 (178.18) | 0.0537^ | 101.3 (271.91) | 92.5 (317.86) | 109.9 (219.27) | 0.0564^ |
International normalized ratio (INR), Mean (SD) | 1.3 (0.53) | 1.4 (0.65) | 1.3 (0.46) | 0.5287^ | 1.3 (0.60) | 1.4 (0.66) | 1.3 (0.55) | 0.8566^ |
Total Bilirubin, Mean (SD) | 37.5 (86.08) | 33.8 (72.26) | 39.5 (92.83) | 0.1594^ | 34.0 (68.26) | 33.8 (72.73) | 34.2 (63.84) | 0.1658^ |
White blood cells (WBCs), Mean (SD) | 13.0 (8.17) | 12.5 (7.80) | 13.3 (8.36) | 0.4028^ | 13.0 (7.72) | 12.6 (7.96) | 13.4 (7.50) | 0.2366^ |
Maximum temperature (T max)), Mean (SD) | 37.8 (3.14) | 37.9 (3.99) | 37.8 (2.62) | 0.2355^ | 37.7 (2.92) | 37.9 (4.09) | 37.6 (0.80) | 0.3100^ |
Vancomycin | ||||||||
Loading dose, n (%) | 43 (13.2) | 15 (13.8) | 28 (13.0) | 0.8410^^ | 27 (12.9) | 14 (13.5) | 13 (12.4) | 0.8159^^ |
Maintenance dose (mg/kg/day), Mean (SD) | 25.9 (12.16) | 24.2 (11.10) | 26.8 (12.62) | 0.0909^ | 26.2 (12.58) | 24.3 (11.19) | 28.1 (13.65) | 0.0524^ |
Initial level of vancomycin trough, Mean (SD) | 8.1 (3.23) | 11.7 (1.18) | 6.3 (2.23) | < .0001* | 9.0 (3.23) | 11.7 (1.17) | 6.3 (2.19) | < .0001* |